https://www.turkmenistanhealthnews.com/article/909502632-steelpower-capsules-for-male-enhancement-support-review-the-ingredients-where-to-buy-to-avoid-complaints Turkmenistan Health News en PressRelease 2026-05-01T00:27:25+00:00 SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints https://zingfast.com/wp-content/uploads/2026/04/Steel-Power-Capsules.jpg https://www.turkmenistanhealthnews.com/article/909494721-rein-therapeutics-announces-pricing-of-50-million-underwritten-public-offering-of-common-stock Turkmenistan Health News en PressRelease 2026-05-01T00:00:00+00:00 Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock https://ml.globenewswire.com/media/7012d0d8-d19b-4f82-be65-c10f3701019b/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909486526-correction-helus-pharma-partners-with-tara-mind-to-advance-veteran-mental-health Turkmenistan Health News en PressRelease 2026-04-30T23:17:38+00:00 CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health  https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.turkmenistanhealthnews.com/article/909486341-leanzene-gummies-under-investigation-2026-official-website-scam-warning-update-avoid-fake-complaints-hidden-risks Turkmenistan Health News en PressRelease 2026-04-30T23:10:16+00:00 Leanzene Gummies Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks https://zingfast.com/wp-content/uploads/2026/04/Leanzene-Gummies-Scam-Warning.jpg https://www.turkmenistanhealthnews.com/article/909478424-hemab-therapeutics-announces-pricing-of-upsized-initial-public-offering Turkmenistan Health News en PressRelease 2026-04-30T22:55:19+00:00 Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/ODA2NTAwNWItYjg4Mi00M2QxLTk5MGMtYWQwYjJlMGZiNzYzLTEzMjE4MjEtMjAyNi0wNC0zMC1lbg==/tiny/Hemab-Therapeutics-Inc-.png https://www.turkmenistanhealthnews.com/article/909477746-american-nurses-association-s-statement-on-the-department-of-education-s-finalized-graduate-student-loan-rulemaking Turkmenistan Health News en PressRelease 2026-04-30T22:31:35+00:00 American Nurses Association’s Statement on the Department of Education’s Finalized Graduate Student Loan Rulemaking https://ml.globenewswire.com/media/MzdmNTExM2YtZDJjNi00NzE2LTlkN2EtMjc1YzljNTY0YmU1LTUwMDE2MTk2Mi0yMDI2LTA0LTMwLWVu/tiny/American-Nurses-Enterprise.png https://www.turkmenistanhealthnews.com/article/909469904-intercure-announces-2025-results-with-nis-270-million-in-revenue-and-positive-operating-cash-flow Turkmenistan Health News en PressRelease 2026-04-30T22:05:00+00:00 InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow https://ml.globenewswire.com/media/7ccabaed-d117-4a39-a756-85fc081ede2f/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909469626-totus-medicines-to-present-interim-phase-1b-clinical-data-for-tos-358-fulvestrant-doublet-therapy-in-hr-her-breast-cancer-patients-at-esmo-breast Turkmenistan Health News en PressRelease 2026-04-30T22:00:00+00:00 Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026 https://ml.globenewswire.com/media/3eba21cf-0a86-45b2-a9f6-405a8ffbe407/small/totus-modularlogo-orange-01-50-jpg.jpg https://www.turkmenistanhealthnews.com/article/909469635-yd-bio-limited-reports-full-year-2025-financial-results Turkmenistan Health News en PressRelease 2026-04-30T22:00:00+00:00 YD Bio Limited Reports Full Year 2025 Financial Results https://ml.globenewswire.com/media/MGExZGVjMTUtYWE4NS00NTJlLWIxYTMtMGRiY2MxYWVkNTI4LTUwMDE1MjY3MC0yMDI2LTA0LTMwLWVu/tiny/YD-Bio-Limited.png https://www.turkmenistanhealthnews.com/article/909469659-fibrobiologics-reports-q1-2026-financial-results-and-provides-corporate-update Turkmenistan Health News en PressRelease 2026-04-30T21:55:00+00:00 FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.turkmenistanhealthnews.com/article/909469567-leo-international-precision-health-ag-berichtet-ber-finanzergebnisse-2025-und-schafft-strategische-grundlage-f-r-eine-ki-gest-tzte Turkmenistan Health News en PressRelease 2026-04-30T21:50:00+00:00 Leo International Precision Health AG berichtet über Finanzergebnisse 2025 und schafft strategische Grundlage für eine KI-gestützte Precision-Health-Plattform https://ml-eu.globenewswire.com/media/MmNlMzYxMmYtM2FlNC00MzFjLWE1MWMtMTNlNjRiMjdmOGI4LTEzMTY3NDEtMjAyNi0wNC0zMC1kZQ==/tiny/Leo-International-Precision-He.png https://www.turkmenistanhealthnews.com/article/909469603-leo-international-precision-health-ag-reports-2025-results-and-establishes-strategic-foundation-for-ai-driven-precision-health-platform Turkmenistan Health News en PressRelease 2026-04-30T21:50:00+00:00 Leo International Precision Health AG Reports 2025 Results and Establishes Strategic Foundation for AI-Driven Precision Health Platform https://ml-eu.globenewswire.com/media/MmNlMzYxMmYtM2FlNC00MzFjLWE1MWMtMTNlNjRiMjdmOGI4LTEzMTY3NDEtMjAyNi0wNC0zMC1lbg==/tiny/Leo-International-Precision-He.png https://www.turkmenistanhealthnews.com/article/909461052-tlx101-px-pixlumi-maa-accepted-in-europe Turkmenistan Health News en PressRelease 2026-04-30T21:43:44+00:00 TLX101-Px (Pixlumi®) MAA Accepted in Europe https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.turkmenistanhealthnews.com/article/909461100-mygriefangels-org-launches-grief-work-insights-hub-to-bridge-the-support-gap-in-the-modern-workplace Turkmenistan Health News en PressRelease 2026-04-30T21:38:10+00:00 MyGriefAngels.org Launches "Grief @ Work Insights" Hub to Bridge the Support Gap in the Modern Workplace https://pressranger.s3.us-west-1.amazonaws.com/3239520/GriefAtWorkPlaceNumbers.jpg https://www.turkmenistanhealthnews.com/article/909461019-the-oaks-residence-announces-grand-opening-and-open-house Turkmenistan Health News en PressRelease 2026-04-30T21:30:36+00:00 The Oaks Residence Announces Grand Opening and Open House https://ml.globenewswire.com/media/1366ae35-ff0c-449b-9697-fd4581a19863/small/the-oaks-new-logo-march-2026-logo-3-png.png https://www.turkmenistanhealthnews.com/article/909453502-rakovina-therapeutics-inc-announces-2025-financial-results-and-provides-corporate-update Turkmenistan Health News en PressRelease 2026-04-30T21:10:00+00:00 Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/e94148e0-0631-403b-9597-c742d43dca13/small/rakovina-logo-mar2021-png.png https://www.turkmenistanhealthnews.com/article/909453399-stryker-brad-saar-sonablate Turkmenistan Health News en PressRelease 2026-04-30T20:49:33+00:00 前 Stryker 医疗事业部总裁 Brad Saar 加入 Sonablate 董事会，将助力无创前列腺癌治疗业务增长 https://ml.globenewswire.com/media/dc6636f6-7b53-461a-9684-b8391c5ca4b0/small/sonablate-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909453224-tela-bio-announces-strategic-board-refreshment-with-four-highly-experienced-commerical-leaders-to-accelerate-growth-and-drive-path-to-profitability Turkmenistan Health News en PressRelease 2026-04-30T20:43:11+00:00 TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://www.turkmenistanhealthnews.com/article/909446524-new-nevada-community-health-needs-assessment-and-implementation-strategy-from-intermountain-health-released Turkmenistan Health News en PressRelease 2026-04-30T20:33:41+00:00 New Nevada Community Health Needs Assessment and Implementation Strategy from Intermountain Health Released https://ml.globenewswire.com/media/Njg4YzllNjgtNmEwMS00MmQ3LTk0ZmQtMTU3MGNiMTZjODQ3LTEyNjkxMjYtMjAyNi0wNC0zMC1lbg==/tiny/Intermountain-Health.png https://www.turkmenistanhealthnews.com/article/909445330-dbv-technologies-reports-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-30T20:30:00+00:00 DBV Technologies Reports First Quarter 2026 Financial Results https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/logo1-jpg.jpg https://www.turkmenistanhealthnews.com/article/909445335-dbv-technologies-publie-ses-r-sultats-financiers-du-1er-trimestre-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:30:00+00:00 DBV Technologies publie ses résultats financiers du 1er trimestre 2026 https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/ https://www.turkmenistanhealthnews.com/article/909445351-alvotech-announces-a-change-in-its-executive-team Turkmenistan Health News en PressRelease 2026-04-30T20:30:00+00:00 Alvotech Announces a Change in its Executive Team https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909446514-emergent-biosolutions-reports-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-30T20:30:00+00:00 Emergent BioSolutions Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://www.turkmenistanhealthnews.com/article/909446058-cue-biopharma-announces-30-million-private-placement Turkmenistan Health News en PressRelease 2026-04-30T20:25:00+00:00 Cue Biopharma Announces $30 Million Private Placement https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.turkmenistanhealthnews.com/article/909446003-hcw-biologics-announces-adjournment-of-special-meeting-of-stockholders-due-to-lack-of-quorum Turkmenistan Health News en PressRelease 2026-04-30T20:20:00+00:00 HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.turkmenistanhealthnews.com/article/909446064-cue-biopharma-expands-pipeline-with-exclusive-license-from-ascendant-health-sciences-ltd-for-clinical-stage-dual-mechanism-anti-ige-antibody Turkmenistan Health News en PressRelease 2026-04-30T20:15:00+00:00 Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.turkmenistanhealthnews.com/article/909446186-coopercompanies-announces-release-date-for-second-quarter-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:15:00+00:00 CooperCompanies Announces Release Date for Second Quarter 2026 https://ml.globenewswire.com/media/10a4810f-301c-4d8c-851d-dd09334d10d5/small/coopercompanies-aqua-logo-horz-jpg.jpg https://www.turkmenistanhealthnews.com/article/909446396-physical-rehabilitation-network-memorialcare-open-new-outpatient-physical-therapy-clinic-in-garden-grove Turkmenistan Health News en PressRelease 2026-04-30T20:11:56+00:00 Physical Rehabilitation Network & MemorialCare Open New Outpatient Physical Therapy Clinic in Garden Grove https://ml.globenewswire.com/media/NWEzNjhlNTAtMmFjOS00NWRjLTllZDgtMjExMjcxMDE3ODY1LTEyMTcwODEtMjAyNi0wNC0zMC1lbg==/tiny/Physical-Rehabilitation-Networ.png https://www.turkmenistanhealthnews.com/article/909446485-the-ensign-group-reports-first-quarter-2026-results-raises-2026-annual-earnings-and-revenue-guidance Turkmenistan Health News en PressRelease 2026-04-30T20:11:09+00:00 The Ensign Group Reports First Quarter 2026 Results; Raises 2026 Annual Earnings and Revenue Guidance https://ml.globenewswire.com/media/43cc375c-326e-4962-89ff-3f917599b33f/small/the-ensign-group-inc-logo.jpg https://www.turkmenistanhealthnews.com/article/909445515-resmed-chief-financial-officer-brett-sandercock-to-retire-aaron-bloomer-appointed-as-successor Turkmenistan Health News en PressRelease 2026-04-30T20:10:00+00:00 Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor  https://ml.globenewswire.com/media/fb7a34f4-d074-4bcf-b827-7a6a60924c46/small/resmed-h-pos-clr-rgb-250121-png.png https://www.turkmenistanhealthnews.com/article/909445673-si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:09:00+00:00 SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026 https://ml.globenewswire.com/media/1630843d-d109-4819-9c6f-455c684690ba/small/sibn-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909437639-nyxoah-to-participate-in-the-bank-of-america-2026-healthcare-conference Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Nyxoah to Participate in the Bank of America 2026 Healthcare Conference https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://www.turkmenistanhealthnews.com/article/909437652-nyxoah-participera-la-conf-rence-bank-of-america-2026-healthcare Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Nyxoah Participera à la Conférence Bank of America 2026 Healthcare https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://www.turkmenistanhealthnews.com/article/909437664-aligos-therapeutics-to-announce-1st-quarter-2026-financial-results-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://www.turkmenistanhealthnews.com/article/909437674-radnet-and-trinity-health-s-saint-alphonsus-health-system-launch-a-multi-site-joint-venture-in-boise-idaho-to-include-a-broad-technology-deployment Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 RadNet and Trinity Health’s Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions https://ml.globenewswire.com/media/0df5f357-aa64-4998-a83f-f1561aef685d/small/logo-radnet-profile2-jpg.jpg https://www.turkmenistanhealthnews.com/article/909437676-capsovision-to-release-first-quarter-2026-financial-results-on-may-14-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 https://ml.globenewswire.com/media/3762c13c-02bc-43fe-85be-1808d440f15a/small/capsovision-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909437695-cocrystal-pharma-presentation-at-icar-2026-highlights-mechanism-of-action-and-clinical-advancement-of-cdi-988-for-the-prevention-and-treatment-of Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection https://ml.globenewswire.com/media/a5071a3a-c592-43ba-bfee-77c2867982ba/small/cocrystal-logo-final-highres-792x612-png.png https://www.turkmenistanhealthnews.com/article/909437809-biostem-technologies-to-host-first-quarter-2026-financial-results-conference-call-on-may-14-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026 https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.turkmenistanhealthnews.com/article/909437817-merit-medical-reports-first-quarter-2026-results-and-updates-full-year-guidance Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://www.turkmenistanhealthnews.com/article/909437862-trevi-therapeutics-announces-oral-presentation-and-multiple-posters-accepted-at-the-american-thoracic-society-ats-2026-international-conference Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909437932-elutia-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 https://ml.globenewswire.com/media/9818bf87-5594-4aae-aa0a-315674cd415b/small/elutia-hires-logo-1200x630-png.png https://www.turkmenistanhealthnews.com/article/909437970-echo-iq-announces-echosolv-as-deployed-into-mount-sinai-health-system Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System https://ml.globenewswire.com/media/961a558d-131b-43cc-a71e-05eb7bc71bc5/small/echoiq-png.png https://www.turkmenistanhealthnews.com/article/909437987-akebia-therapeutics-to-report-first-quarter-2026-financial-results-and-discuss-recent-business-highlights Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.turkmenistanhealthnews.com/article/909438032-century-therapeutics-selected-for-oral-presentation-of-cnty-813-preclinical-data-at-the-american-diabetes-association-86th-scientific-sessions Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png https://www.turkmenistanhealthnews.com/article/909438222-stryker-reports-first-quarter-2026-operating-results Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Stryker reports first quarter 2026 operating results https://ml.globenewswire.com/media/c24fe8bd-9db6-4f42-8a52-06a4e1b673b5/small/stryker-logo2015-jpg.jpg https://www.turkmenistanhealthnews.com/article/909438248-larimar-therapeutics-publishes-cross-species-findings-supporting-skin-as-a-surrogate-for-the-measurement-of-frataxin-in-tissues-clinically-relevant-to Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia https://ml.globenewswire.com/media/b02e1010-493d-4ec7-8523-c59602684d09/small/lrmr-logo-png.png https://www.turkmenistanhealthnews.com/article/909438311-resmed-inc-announces-results-for-the-third-quarter-of-fiscal-year-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026 https://ml.globenewswire.com/media/fb7a34f4-d074-4bcf-b827-7a6a60924c46/small/resmed-h-pos-clr-rgb-250121-png.png https://www.turkmenistanhealthnews.com/article/909438371-cue-biopharma-names-shao-lee-lin-m-d-ph-d-ceo-president-and-board-director-to-lead-continued-growth-and-transformation-into-a-clinical-stage Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.turkmenistanhealthnews.com/article/909438385-orthopediatrics-corp-reports-first-quarter-2026-financial-results-and-increases-2026-financial-guidance Turkmenistan Health News en PressRelease 2026-04-30T20:05:00+00:00 OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance https://ml.globenewswire.com/media/b05026f8-f835-4f46-a103-232db9c6c025/small/ortho-jpg.jpg https://www.turkmenistanhealthnews.com/article/909437668-procept-biorobotics-to-attend-three-upcoming-investor-conferences-in-may-june Turkmenistan Health News en PressRelease 2026-04-30T20:03:00+00:00 PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June https://ml.globenewswire.com/media/fc9b1b79-13a0-4245-a974-081e3ceaafcb/small/procept-logo-png.PNG https://www.turkmenistanhealthnews.com/article/909438521-senseonics-announces-commencement-of-80-million-public-offering-of-common-stock-and-pre-funded-warrants Turkmenistan Health News en PressRelease 2026-04-30T20:01:53+00:00 Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909437730-the-ensign-group-acquires-real-estate-and-expands-operations-in-texas Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 The Ensign Group Acquires Real Estate and Expands Operations in Texas https://ml.globenewswire.com/media/43cc375c-326e-4962-89ff-3f917599b33f/small/the-ensign-group-inc-logo.jpg https://www.turkmenistanhealthnews.com/article/909437740-the-ensign-group-purchases-facilities-in-wisconsin Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 The Ensign Group Purchases Facilities in Wisconsin https://ml.globenewswire.com/media/43cc375c-326e-4962-89ff-3f917599b33f/small/the-ensign-group-inc-logo.jpg https://www.turkmenistanhealthnews.com/article/909437812-xenon-to-report-q1-2026-financial-results-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 Xenon to Report Q1 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.turkmenistanhealthnews.com/article/909437814-ardelyx-reports-first-quarter-2026-financial-results-and-provides-business-update Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://www.turkmenistanhealthnews.com/article/909437852-pacira-biosciences-reports-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 Pacira BioSciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.turkmenistanhealthnews.com/article/909437939-alignment-healthcare-delivers-strong-first-quarter-2026-results-demonstrating-disciplined-growth-and-margin-expansion Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion https://ml.globenewswire.com/media/c6122501-032d-4425-bb0d-759ee3d3fe68/small/alignmenthealthcare-primary-logo-verticala-png.png https://www.turkmenistanhealthnews.com/article/909438169-syndax-reports-first-quarter-2026-financial-results-and-provides-business-update Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 Syndax Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909438259-orthopediatrics-expands-specialty-bracing-portfolio-with-traxio-halo-gravity-traction-system Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System https://ml.globenewswire.com/media/b05026f8-f835-4f46-a103-232db9c6c025/small/ortho-jpg.jpg https://www.turkmenistanhealthnews.com/article/909438283-ascendis-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T20:01:00+00:00 Ascendis to Report First Quarter 2026 Financial Results and Provide Business Update on May 7, 2026 https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.turkmenistanhealthnews.com/article/909437649-mdxhealth-to-release-first-quarter-2026-financial-results-on-may-13 Turkmenistan Health News en PressRelease 2026-04-30T20:00:00+00:00 Mdxhealth to Release First Quarter 2026 Financial Results on May 13 https://ml-eu.globenewswire.com/media/695db10e-2b5a-44e3-af73-a3dea1ead37c/small/mdxhealth-logo-full-color-rgb-png.png https://www.turkmenistanhealthnews.com/article/909438237-nephros-schedules-first-quarter-2026-financial-results-conference-call Turkmenistan Health News en PressRelease 2026-04-30T20:00:00+00:00 Nephros Schedules First Quarter 2026 Financial Results Conference Call https://ml.globenewswire.com/media/47f2ed6d-a81f-4174-a3eb-0a46a538285e/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909430332-greenhouse-treatment-center-bolsters-behavioral-health-team-with-two-experienced-psychiatric-nurse-practitioners Turkmenistan Health News en PressRelease 2026-04-30T19:15:00+00:00 Greenhouse Treatment Center Bolsters Behavioral Health Team with Two Experienced Psychiatric Nurse Practitioners https://ml.globenewswire.com/media/b254f457-99ad-4002-913e-62f00a10b069/medium/adedeji-ade-babajide-pmhnp-bc.png https://www.turkmenistanhealthnews.com/article/909430276-engeneic-announces-first-patient-dosed-in-recurrent-glioblastoma-clinical-trial Turkmenistan Health News en PressRelease 2026-04-30T19:07:26+00:00 EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial https://ml.globenewswire.com/media/e29e6b77-ee21-4796-890d-65f535c327a9/small/engeneic-logo-png.png https://www.turkmenistanhealthnews.com/article/909422920-abbvie-et-admare-bioinnovations-nomment-rime-therapeutics-laur-at-du-prix-abbvie-des-innovateurs-en-biotechnologies-au-qu-bec Turkmenistan Health News en PressRelease 2026-04-30T19:00:00+00:00 AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec https://ml.globenewswire.com/media/Y2YyYTAzMjUtYTMzYy00MzZiLWE4Y2ItMTk5YWNhZjA0NGQ3LTUwMDE1NTMwOC0yMDI2LTA0LTMwLWZy/tiny/AbbVie-Canada.png https://www.turkmenistanhealthnews.com/article/909422954-abbvie-and-admare-bioinnovations-announce-rime-therapeutics-as-abbvie-biotech-innovators-award-recipient-in-quebec Turkmenistan Health News en PressRelease 2026-04-30T19:00:00+00:00 AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec https://ml.globenewswire.com/media/YmVmNDViMGQtZTEwOC00YmVhLWEyOTUtYTk1ZjFmZjIxOTQ1LTUwMDE1NTMwOC0yMDI2LTA0LTMwLWVu/tiny/AbbVie-Canada.png https://www.turkmenistanhealthnews.com/article/909415538-axsome-therapeutics-announces-fda-approval-of-auvelity-dextromethorphan-hbr-and-bupropion-hcl-for-the-treatment-of-agitation-associated-with Turkmenistan Health News en PressRelease 2026-04-30T18:06:04+00:00 Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease https://ml.globenewswire.com/media/1186f248-bfb6-4258-a391-f2ffd94c5d76/small/axsome-r-morpheus-logo-pos-rgb-png.png https://www.turkmenistanhealthnews.com/article/909395870-sofanya-launches-highly-anticipated-sacred-body-oil-just-in-time-for-mother-s-day-this-isn-t-about-doing-more-it-s-about-coming-back Turkmenistan Health News en PressRelease 2026-04-30T16:47:56+00:00 Sofanya Launches Highly Anticipated Sacred Body Oil Just in Time for Mother's Day: 'this isn't about doing more, it's about coming back' https://ml.globenewswire.com/media/646e1057-56ea-470c-bdd3-5c9fde910040/small/sofanya-logo.jpeg https://www.turkmenistanhealthnews.com/article/909395878-ocubio-announces-appointment-of-jim-mazzo-and-dr-eric-donnenfeld-as-strategic-advisors Turkmenistan Health News en PressRelease 2026-04-30T16:40:32+00:00 Ocubio Announces Appointment of Jim Mazzo and Dr. Eric Donnenfeld as Strategic Advisors https://ml.globenewswire.com/media/NTIzMTg2ZDEtNTFhNS00ZDJiLWI2ZmItNjczNWQ4NGRjODRmLTEzMjI5NjYtMjAyNi0wNC0zMC1lbg==/tiny/Ocubio.png https://www.turkmenistanhealthnews.com/article/909389534-kai-conversations-announces-strategic-partnership-with-syneos-health-to-advance-u-s-pharmaceutical-commercialization Turkmenistan Health News en PressRelease 2026-04-30T16:30:00+00:00 KAI Conversations Announces Strategic Partnership with Syneos Health to Advance U.S. Pharmaceutical Commercialization https://ml.globenewswire.com/media/NDhmY2ViNDktMTIxMC00MDZhLThlZTktYmM0MmU2MWM1YzYyLTEwMTU4MjItMjAyNi0wNC0zMC1lbg==/tiny/Syneos-Health-Inc-.png https://www.turkmenistanhealthnews.com/article/909377197-confo-therapeutics-announces-phase-2-clinical-trial-initiation-by-lilly-for-peripheral-pain-candidate-cftx-1554 Turkmenistan Health News en PressRelease 2026-04-30T15:30:00+00:00 Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554 https://ml-eu.globenewswire.com/media/a9fcac03-0dcc-4a7b-b073-1b8fe4c6cf72/small/2026-confo-logo-png.png https://www.turkmenistanhealthnews.com/article/909371959-zealand-pharma-conference-call-on-may-7-at-2pm-cet-8am-et-to-present-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-30T15:01:00+00:00 Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.turkmenistanhealthnews.com/article/909366113-ground-breaking-for-intermountain-health-fillmore-community-hospital-emergency-department-expansion-will-enhance-access-to-care-in-region Turkmenistan Health News en PressRelease 2026-04-30T14:39:55+00:00 Ground Breaking for Intermountain Health Fillmore Community Hospital Emergency Department Expansion Will Enhance Access to Care in Region https://ml.globenewswire.com/media/ODc4NjdiMjQtMjZkYy00MGViLTgwODctMDA2OGQ4MTMwMDMwLTEyNjkxMjYtMjAyNi0wNC0zMC1lbg==/tiny/Intermountain-Health.png https://www.turkmenistanhealthnews.com/article/909366097-biorestorative-therapies-to-present-new-data-at-isct-2026-highlighting-its-ongoing-phase-2-clinical-trial-in-chronic-lumbar-disease-and-its Turkmenistan Health News en PressRelease 2026-04-30T14:36:00+00:00 BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909360663-timelycare-expands-its-basic-needs-service-to-help-colleges-better-support-student-retention Turkmenistan Health News en PressRelease 2026-04-30T14:15:00+00:00 TimelyCare Expands Its Basic Needs Service to Help Colleges Better Support Student Retention https://ml.globenewswire.com/media/ca99d677-dd92-4104-9e0b-ec6958d5d377/small/ https://www.turkmenistanhealthnews.com/article/909360684-centre-for-neuro-skills-ceo-david-harrington-joins-brain-to-brain-podcast-to-discuss-the-science-of-recovery-advocacy-for-brain-injury-care-and-why Turkmenistan Health News en PressRelease 2026-04-30T14:10:00+00:00 Centre for Neuro Skills CEO David Harrington Joins Brain to Brain Podcast to Discuss the Science of Recovery, Advocacy for Brain Injury Care and Why It Is Never Too Late https://ml.globenewswire.com/media/43373264-6b03-474c-bac7-ecf4844a95bd/medium/david-harrington-and-evan-folan.png https://www.turkmenistanhealthnews.com/article/909360753-aua-and-openevidence-collaborate-to-expand-access-to-evidence-based-urologic-clinical-practice-guidelines Turkmenistan Health News en PressRelease 2026-04-30T14:05:00+00:00 AUA and OpenEvidence Collaborate to Expand Access to Evidence-Based Urologic Clinical Practice Guidelines https://ml.globenewswire.com/media/NDAwYWM1ZjEtOGIyNC00ZGY3LWIwZTctYjRjY2U2MTFmNWZmLTEyNzYxOTAtMjAyNi0wNC0zMC1lbg==/tiny/American-Urological-Associatio.png https://www.turkmenistanhealthnews.com/article/909355749-psychemedics-releases-2026-workforce-insights-report Turkmenistan Health News en PressRelease 2026-04-30T14:00:00+00:00 Psychemedics Releases 2026 Workforce Insights Report https://ml.globenewswire.com/media/b2b4d705-cbfa-4454-b34d-791c4cc1a95d/small/psychemdicslogo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909355767-willow-glow-wellness-spa-clinics-announces-advanced-led-facelift-protocol-attracting-silicon-valley-clients-for-non-surgical-skin-rejuvenation Turkmenistan Health News en PressRelease 2026-04-30T14:00:00+00:00 Willow Glow Wellness Spa Clinics Announces Advanced LED Facelift Protocol, Attracting Silicon Valley Clients for Non-Surgical Skin Rejuvenation https://pressranger.s3.us-west-1.amazonaws.com/3236534/Willow-Glow-Wellness-Spa-Clinics.jpg https://www.turkmenistanhealthnews.com/article/909355790-youthcommerce-unveils-phiflow-a-revolutionary-operating-standard-for-clinics Turkmenistan Health News en PressRelease 2026-04-30T14:00:00+00:00 YouthCommerce Unveils PhiFlow: A Revolutionary Operating Standard for Clinics https://pressranger.s3.us-west-1.amazonaws.com/3238461/WhatsApp-Image-2026-04-30-at-00.27.26-%281%29.jpeg https://www.turkmenistanhealthnews.com/article/909351300-health-catalyst-appoints-steve-nelson-president-of-aetna-to-its-board-of-directors Turkmenistan Health News en PressRelease 2026-04-30T13:27:50+00:00 Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors https://ml.globenewswire.com/media/95973775-03d2-4696-b65c-c43ff730af3a/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/909350993-kraig-labs-clears-dual-commercialization-milestones-with-record-spider-silk-production-and-successful-reeling-operations Turkmenistan Health News en PressRelease 2026-04-30T13:20:00+00:00 Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations https://ml.globenewswire.com/media/528d80d7-f9ef-40f6-809b-ba259822f33a/medium/some-of-kraig-labs-recently-reeled-recombinant-spider-silk.PNG https://www.turkmenistanhealthnews.com/article/909346018-myriad-genetics-national-survey-88-of-patients-with-depression-and-or-anxiety-would-feel-more-confident-with-a-personalized-mental-health-care-plan Turkmenistan Health News en PressRelease 2026-04-30T13:05:00+00:00 Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.turkmenistanhealthnews.com/article/909346053-former-stryker-medical-division-president-brad-saar-joins-sonablate-board-to-support-growth-of-non-invasive-prostate-cancer-treatment Turkmenistan Health News en PressRelease 2026-04-30T13:03:00+00:00 Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment https://ml.globenewswire.com/media/dc6636f6-7b53-461a-9684-b8391c5ca4b0/small/sonablate-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909345937-vivus-announces-qsiva-price-reduction-across-nordics-and-poland Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland https://ml-eu.globenewswire.com/media/900f9144-8898-470f-b890-333d03292228/small/vivus-wordmark-blue-400x130-2x-rgb-png.png https://www.turkmenistanhealthnews.com/article/909345945-vivus-og-asza-obni-k-ceny-produktu-qsiva-w-krajach-nordyckich-i-w-polsce Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 VIVUS ogłasza obniżkę ceny produktu QSIVA® w krajach nordyckich i w Polsce https://ml-eu.globenewswire.com/media/900f9144-8898-470f-b890-333d03292228/small/ https://www.turkmenistanhealthnews.com/article/909346005-new-york-blood-center-enterprises-and-biohub-launch-collaboration-to-advance-cord-blood-derived-stem-cell-platforms Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms https://ml.globenewswire.com/media/bd7263c3-72fd-4933-8d98-a18a581f0a6e/small/nybce-logo-2-color-jpg.jpg https://www.turkmenistanhealthnews.com/article/909346076-glucotrack-announces-publication-of-peer-reviewed-study-in-the-journal-of-diabetes-research-demonstrating-long-term-accuracy-and-stability-of Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://www.turkmenistanhealthnews.com/article/909346093-a-d-a-m-innovations-enables-pharmacogenomics-for-ntt-precision-medicine Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine https://ml.globenewswire.com/media/57b381e4-7649-49a9-bf54-e247c5a8cf1f/small/adam-innovations-horizontal-png.png https://www.turkmenistanhealthnews.com/article/909346289-fate-therapeutics-announces-data-presentation-of-ft819-off-the-shelf-car-t-cell-product-candidate-for-systemic-lupus-erythematosus-sle-at-the-ccr Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.turkmenistanhealthnews.com/article/909346313-alkeus-pharmaceuticals-announces-presentation-of-gildeuretinol-data-during-the-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting https://ml.globenewswire.com/media/fd46716f-cd58-41ed-99f3-9c111a393d15/small/alkeus-pharma-logo-2024-png.png https://www.turkmenistanhealthnews.com/article/909346358-precision-neuroscience-partners-with-uchicago-medicine-researchers-to-advance-brain-computer-interface-research Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 Precision Neuroscience™ Partners With UChicago Medicine Researchers to Advance Brain–Computer Interface Research https://ml.globenewswire.com/media/30f132af-7046-4849-993d-ae830a076476/small/pn-logo-jpg.png https://www.turkmenistanhealthnews.com/article/909346394-fda-grants-orchestra-biomed-additional-breakthrough-device-designation-for-avim-therapy Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.turkmenistanhealthnews.com/article/909346422-ernexa-therapeutics-announces-1-for-25-reverse-stock-split Turkmenistan Health News en PressRelease 2026-04-30T13:00:00+00:00 Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.turkmenistanhealthnews.com/article/909346243-avita-medical-names-cary-vance-as-chief-executive-officer Turkmenistan Health News en PressRelease 2026-04-30T12:50:00+00:00 AVITA Medical Names Cary Vance as Chief Executive Officer https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.turkmenistanhealthnews.com/article/909341318-can-fite-reports-positive-phase-2a-data-with-namodenoson-in-pancreatic-cancer-35-of-patients-remain-on-therapy-including-one-beyond-16-months Turkmenistan Health News en PressRelease 2026-04-30T12:31:35+00:00 Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months https://ml.globenewswire.com/media/ca5e71b0-5c40-4d54-96ce-7ce704201c96/small/can-fite-biopharma-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909340879-teva-s-2025-healthy-future-report-highlights-environmental-and-access-to-medicines-progress-including-meeting-all-sustainability-linked-bond-targets Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.turkmenistanhealthnews.com/article/909340880-vvt-med-announces-positive-clinical-data-for-sclerosafe-r-published-in-peer-reviewed-indian-journal-of-vascular-and-endovascular-surgery Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery https://ml-eu.globenewswire.com/media/7ee51e55-03a5-402b-887f-1c43066d7063/small/logo-303-png.png https://www.turkmenistanhealthnews.com/article/909340890-edap-tms-strengthens-market-position-with-landmark-hifi-2-data-supporting-focal-one-robotic-hifu-in-radiorecurrent-prostate-cancer Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer https://ml-eu.globenewswire.com/media/ded19329-9645-4860-ac2d-bf3e2422b649/small/focalone-square-logo-drkblue-web-400-1-png.png https://www.turkmenistanhealthnews.com/article/909341001-kriya-announces-presentations-at-asgct-2026-highlighting-advances-across-gene-therapy-platform Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform https://ml.globenewswire.com/media/499a8479-725f-44cf-b768-37a114f16b5e/small/kriya-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341010-pliant-therapeutics-announces-first-patient-dosed-in-fortify-the-phase-1b-indication-expansion-trial-evaluating-pln-101095-in-patients-with Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341014-enlivex-treasury-portfolio-update-listing-of-the-rain-token-on-htx-a-leading-cryptocurrency-exchange Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341017-oncotelic-therapeutics-advances-toward-commercial-launch-of-ai-enabled-robotics-platform-following-integration-of-28-million-scientific-abstracts Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Oncotelic Therapeutics Advances Toward Commercial Launch of AI-Enabled Robotics Platform Following Integration of 28 Million Scientific Abstracts https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341040-spectral-ai-wins-small-business-innovator-award-at-inaugural-texas-innovation-conference Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Spectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation Conference https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341073-quoin-pharmaceuticals-to-announce-corporate-update-and-first-quarter-2026-financial-results-on-thursday-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026 https://ml.globenewswire.com/media/7002de7e-dd04-45a5-a382-625d5317dbfd/small/quoin-colored-logo-png-png.png https://www.turkmenistanhealthnews.com/article/909341096-cadrenal-therapeutics-announces-end-of-phase-2-meeting-with-the-fda-and-pivotal-phase-3-registration-path-for-cad-1005-in-heparin-induced Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT) https://ml.globenewswire.com/media/dec0fe5d-b262-4ca7-94e0-1fd3856d07a8/small/cvkd-logo-2025-png.png https://www.turkmenistanhealthnews.com/article/909341123-vicarious-surgical-reports-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Vicarious Surgical Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/YWM2NTM0NGItOThhNS00OTcxLTg0NjctZjY2MTlkZjMwMTZkLTEyMTM5OTQtMjAyNi0wNC0zMC1lbg==/tiny/Vicarious-Surgical.png https://www.turkmenistanhealthnews.com/article/909341127-microbot-medical-announces-the-addition-of-senior-commercial-executive-with-proven-track-record-to-accelerate-commercial-readiness-in-europe-the Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341169-fibrobiologics-announces-poster-presentation-at-the-society-for-investigative-dermatology-annual-meeting-2026 Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026 https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.turkmenistanhealthnews.com/article/909341193-opko-health-expands-nicoya-agreement-to-support-rayaldee-commercialization-in-greater-china Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.turkmenistanhealthnews.com/article/909341279-tomi-environmental-solutions-signs-letter-of-intent-for-a-merger-with-carbonium-core-inc-a-u-s-based-producer-of-nuclear-grade-graphite-for Turkmenistan Health News en PressRelease 2026-04-30T12:30:00+00:00 TOMI Environmental Solutions Signs Letter of Intent for a Merger with Carbonium Core, Inc., a U.S.-Based Producer of Nuclear-Grade Graphite for Advanced Reactors and Infrastructure Demands of AI Data Centers https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.turkmenistanhealthnews.com/article/909336755-newcelx-reports-financial-results-for-2025-and-provides-shareholders-with-update-on-accelerated-development-of-type-1-diabetes-treatment-in Turkmenistan Health News en PressRelease 2026-04-30T12:15:00+00:00 NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg https://www.turkmenistanhealthnews.com/article/909336237-sangamo-therapeutics-to-present-pipeline-and-technology-advances-at-the-29th-annual-meeting-of-the-american-society-of-gene-cell-therapy-asgct Turkmenistan Health News en PressRelease 2026-04-30T12:05:00+00:00 Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT) https://ml.globenewswire.com/media/e3084490-aff3-4c15-8036-d94123563fd0/small/sangamo-logotm-11-11zon-png.png https://www.turkmenistanhealthnews.com/article/909336200-pelvic-rehabilitation-medicine-expands-san-antonio-center-with-new-endometriosis-specialists Turkmenistan Health News en PressRelease 2026-04-30T12:04:00+00:00 Pelvic Rehabilitation Medicine Expands San Antonio Center with New Endometriosis Specialists https://ml.globenewswire.com/media/Y2I0ZGE4MGYtM2NmMi00OTNkLWEyYmYtNTg0NTljMmU5MWFiLTUwMDEyNjg3Ni0yMDI2LTA0LTMwLWVu/tiny/Pelvic-Rehabilitation-Medicine.png https://www.turkmenistanhealthnews.com/article/909336831-inspira-and-qarakal-sign-joint-development-agreement-for-cryogenic-interconnects-in-superconducting-quantum-systems Turkmenistan Health News en PressRelease 2026-04-30T12:01:00+00:00 Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://www.turkmenistanhealthnews.com/article/909336129-electrocore-tac-stim-named-national-semifinalist-in-national-safety-council-work-to-zero-challenge Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.turkmenistanhealthnews.com/article/909336141-elicio-therapeutics-to-present-at-the-bank-of-america-healthcare-conference Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Elicio Therapeutics to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/d588dddd-266e-4f3e-930a-d4c5ba15fe31/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909336149-proqr-announces-nomination-of-dr-lykke-hinsch-gylvin-to-its-board-of-directors Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.turkmenistanhealthnews.com/article/909336153-cytomx-therapeutics-to-report-first-quarter-2026-financial-results-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/c252869d-a4c1-4e56-88e8-d80b85d20c35/small/cytomx-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909336184-krystal-biotech-to-present-at-upcoming-scientific-conferences Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Krystal Biotech to Present at Upcoming Scientific Conferences https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.turkmenistanhealthnews.com/article/909336188-inmune-bio-inc-to-report-first-quarter-2026-financial-results-and-provide-corporate-update-on-thursday-may-7th Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909336192-lexicon-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909336196-picard-medical-syncardia-recognizes-banner-health-as-global-leader-and-supporter-in-the-advancement-of-total-artificial-heart-technology Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.turkmenistanhealthnews.com/article/909336298-bioreference-launches-bioreference-direct-expanding-access-to-consumer-initiated-diagnostic-testing-through-a-fully-integrated-digital-platform Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.turkmenistanhealthnews.com/article/909336338-solid-biosciences-to-showcase-a-large-presence-at-the-29th-annual-meeting-of-the-american-society-of-gene-and-cell-therapy Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.turkmenistanhealthnews.com/article/909336397-alx-oncology-announces-that-cd47-biomarker-data-from-clinical-trial-evaluating-evorpacept-zanidatamab-combination-in-advanced-breast-cancer-will-be Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026 https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.turkmenistanhealthnews.com/article/909336543-immutep-receives-nasdaq-notice-of-bid-price-deficiency Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Immutep Receives Nasdaq Notice of Bid Price Deficiency https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.turkmenistanhealthnews.com/article/909336621-immutep-quarterly-activities-report-q3-fy26 Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 Immutep Quarterly Activities Report Q3 FY26 https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.turkmenistanhealthnews.com/article/909336761-urevo-wins-if-design-award-2026-for-ai-powered-wireless-recovery-boots Turkmenistan Health News en PressRelease 2026-04-30T12:00:00+00:00 UREVO Wins iF Design Award 2026 for AI-Powered Wireless Recovery Boots https://ml.globenewswire.com/Resource/Download/757dd5d6-9737-4d31-bc73-5ab49b424ccc/urevo-2.jpeg https://www.turkmenistanhealthnews.com/article/909331351-emergent-biosolutions-receives-approval-from-singapore-health-sciences-authority-for-expanded-indication-of-acam2000-smallpox-and-mpox-vaccinia Turkmenistan Health News en PressRelease 2026-04-30T11:55:00+00:00 Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://www.turkmenistanhealthnews.com/article/909326457-aptose-biosciences-announces-update-on-anticipated-timing-of-closing-of-the-plan-of-arrangement-with-hanmi-pharmaceutical Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical https://ml.globenewswire.com/media/3f4ab307-5947-4ef1-b5b5-c2c66933728a/small/aptose-biosciences-inc-logo.jpg https://www.turkmenistanhealthnews.com/article/909326459-bridgebio-to-report-first-quarter-2026-financial-results-and-commercial-updates-on-may-7-2026-at-4-30-pm-et Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.turkmenistanhealthnews.com/article/909326468-siga-to-host-business-update-call-on-may-7-2026-following-release-of-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results https://ml.globenewswire.com/media/93028aa6-8191-4392-a7b1-447b046cd93b/small/siga-logo-blue-png.png https://www.turkmenistanhealthnews.com/article/909326486-barinthus-bio-reports-first-quarter-2026-financial-results-and-updates-on-corporate-developments Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments https://ml.globenewswire.com/media/284aac16-bab8-47d0-8077-929f11b0088b/small/barinthuslogo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909326518-palvella-therapeutics-to-host-first-quarter-2026-financial-results-and-corporate-update-conference-call-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 Palvella Therapeutics to Host First Quarter 2026 Financial Results and Corporate Update Conference Call on May 7, 2026 https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.turkmenistanhealthnews.com/article/909326529-tg-therapeutics-to-host-conference-call-on-first-quarter-2026-financial-results-and-business-update Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.turkmenistanhealthnews.com/article/909326535-helus-pharma-to-participate-at-the-29th-annual-milken-institute-global-conference Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.turkmenistanhealthnews.com/article/909326559-medicenna-and-fondazione-melanoma-onlus-announce-presentation-on-neocyt-trial-at-asco-2026 Turkmenistan Health News en PressRelease 2026-04-30T11:30:00+00:00 Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.turkmenistanhealthnews.com/article/909326545-alterity-therapeutics-releases-appendix-4c-q3-fy26-quarterly-cash-flow-report-corporate-update Turkmenistan Health News en PressRelease 2026-04-30T11:25:00+00:00 Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.turkmenistanhealthnews.com/article/909326526-aurora-spine-corporation-announces-record-fourth-quarter-and-fy25-financial-results Turkmenistan Health News en PressRelease 2026-04-30T11:15:00+00:00 Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results https://ml.globenewswire.com/media/af1a0a7b-b883-41f9-8c86-a89bad3cc4a4/small/aurora12-jpg.JPG https://www.turkmenistanhealthnews.com/article/909321648-ac-immune-first-quarter-2026-financial-and-corporate-updates Turkmenistan Health News en PressRelease 2026-04-30T11:05:00+00:00 AC Immune First Quarter 2026 Financial and Corporate Updates https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321659-option-care-health-announces-financial-results-for-the-first-quarter-ended-march-31-2026 Turkmenistan Health News en PressRelease 2026-04-30T11:05:00+00:00 Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/OTMwMzk0MzMtYzkxYi00NzYzLTg4MTYtYzRlNDIyNGM0YzZmLTEwMTk5NzQtMjAyNi0wNC0zMC1lbg==/tiny/Option-Care-Health-Inc-.png https://www.turkmenistanhealthnews.com/article/909321723-uniqure-announces-successful-uk-mhra-pre-submission-meeting-for-amt-130-in-huntington-s-disease Turkmenistan Health News en PressRelease 2026-04-30T11:05:00+00:00 uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321633-indivior-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321646-novartis-finalizes-us-manufacturing-and-r-d-expansion-plan-with-seventh-new-facility Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321647-ac-immune-initiates-final-cohort-in-ongoing-phase-1b-2-abate-trial-of-anti-abeta-active-immunotherapy-to-treat-alzheimer-s-disease Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321682-axogen-inc-to-participate-in-the-2026-bank-of-america-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference https://ml.globenewswire.com/media/3e4ffe78-2e9a-4972-915e-28c8477c84c1/small/axogen-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321691-kymera-therapeutics-announces-first-quarter-2026-financial-results-and-provides-a-business-update Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.turkmenistanhealthnews.com/article/909321729-lensar-to-report-first-quarter-2026-results-on-may-8-2026 Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 LENSAR® to Report First Quarter 2026 Results on May 8, 2026 https://ml.globenewswire.com/media/4768eddf-0f87-4479-87f6-6b81f8ff392a/small/lensar-4color-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321738-the-power-of-community-to-improve-asthma-and-allergy-health Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 The Power of Community to Improve Asthma and Allergy Health https://ml.globenewswire.com/media/YWIzMzVhYzUtOWVhOC00NzhmLWE2ODItNjhhZTk1ZjZiYjcwLTExMDE5NjItMjAyNi0wNC0zMC1lbg==/tiny/Asthma-and-Allergy-Foundation-.png https://www.turkmenistanhealthnews.com/article/909321739-cartesian-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.turkmenistanhealthnews.com/article/909321764-sweetwater-brewing-company-and-salt-life-launch-livin-salty-the-ultimate-summer-craft-brew-collaboration Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 SweetWater Brewing Company and Salt Life Launch Livin’ Salty: The Ultimate Summer Craft Brew Collaboration https://ml.globenewswire.com/media/44db68a9-d316-445f-aa24-0359e453f966/medium/livin-salty.jpeg https://www.turkmenistanhealthnews.com/article/909321805-netramark-to-open-the-market-at-the-toronto-stock-exchange-on-may-5-2026 Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 NetraMark To Open The Market At The Toronto Stock Exchange On May 5, 2026 https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.turkmenistanhealthnews.com/article/909321903-biostem-strengthens-leadership-team-with-appointment-of-katherine-gorrell-as-chief-legal-compliance-officer Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.turkmenistanhealthnews.com/article/909321995-royal-columbian-hospital-begins-patient-recruitment-in-arch-biopartners-phase-ii-trial-of-lsalt-peptide-targeting-cs-aki Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Royal Columbian Hospital begins patient recruitment in Arch Biopartners’ Phase II trial of LSALT peptide targeting CS-AKI https://ml.globenewswire.com/media/8fae7e83-0899-4bbc-ba40-0250cdb9aea7/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909322040-verano-announces-strong-first-quarter-2026-financial-results-highlighted-by-208-million-in-revenue Turkmenistan Health News en PressRelease 2026-04-30T11:00:00+00:00 Verano Announces Strong First Quarter 2026 Financial Results Highlighted by $208 Million in Revenue https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://www.turkmenistanhealthnews.com/article/909321761-phathom-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Turkmenistan Health News en PressRelease 2026-04-30T10:59:00+00:00 Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909317221-verano-announces-20-million-share-repurchase-authorization Turkmenistan Health News en PressRelease 2026-04-30T10:35:00+00:00 Verano Announces $20 Million Share Repurchase Authorization https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://www.turkmenistanhealthnews.com/article/909308015-greenwich-lifesciences-provides-update-regarding-form-10-k-filing Turkmenistan Health News en PressRelease 2026-04-30T10:00:00+00:00 Greenwich LifeSciences Provides Update Regarding Form 10-K Filing https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://www.turkmenistanhealthnews.com/article/909308065-northwestern-medicine-opens-15-million-center-expanding-advanced-gastrointestinal-care-to-suburban-chicago Turkmenistan Health News en PressRelease 2026-04-30T10:00:00+00:00 Northwestern Medicine Opens $15 Million Center Expanding Advanced Gastrointestinal Care to Suburban Chicago https://ml.globenewswire.com/media/c818b3e2-cc21-412d-adb9-1907c8973777/medium/center-for-advanced-endoscopy-physician-team.jpg https://www.turkmenistanhealthnews.com/article/909308123-aclarion-delivers-strong-q1-2026-results-with-196-annual-scan-volume-growth-reflecting-accelerating-clinical-adoption Turkmenistan Health News en PressRelease 2026-04-30T10:00:00+00:00 Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909299246-genembryomics-and-genomic-prediction-launch-xgen-pgt-x Turkmenistan Health News en PressRelease 2026-04-30T09:07:33+00:00 GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™ https://ml.globenewswire.com/media/35292517-cd2b-4358-af63-93771c4db2f3/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/909272955-orchard-therapeutics-awarded-innovation-passport-designation-for-otl-201-in-mps-iiia Turkmenistan Health News en PressRelease 2026-04-30T06:30:00+00:00 Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA https://ml.globenewswire.com/media/00f8bc36-9b68-4343-b7fe-1325d14b6393/small/orchard-kkc-logo-rgb-png.png https://www.turkmenistanhealthnews.com/article/909258262-nicox-provides-full-year-2025-financial-results-and-corporate-update Turkmenistan Health News en PressRelease 2026-04-30T05:30:00+00:00 Nicox Provides Full Year 2025 Financial Results and Corporate Update https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/logo-png.png https://www.turkmenistanhealthnews.com/article/909258284-nicox-annonce-ses-r-sultats-financiers-2025-et-fait-un-point-sur-son-activit Turkmenistan Health News en PressRelease 2026-04-30T05:30:00+00:00 Nicox annonce ses résultats financiers 2025 et fait un point sur son activité https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/ https://www.turkmenistanhealthnews.com/article/909258286-valneva-annonce-le-succ-s-d-une-offre-r-serv-e-d-un-montant-de-84-millions-d-euros Turkmenistan Health News en PressRelease 2026-04-30T05:15:00+00:00 Valneva annonce le succès d’une Offre Réservée d’un montant de 84 millions d’euros https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://www.turkmenistanhealthnews.com/article/909258295-valneva-announces-the-successful-completion-of-an-84-million-reserved-offering Turkmenistan Health News en PressRelease 2026-04-30T05:15:00+00:00 Valneva Announces the Successful Completion of an €84 million Reserved Offering https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://www.turkmenistanhealthnews.com/article/909252187-santhera-schl-gt-dr-srishti-gupta-als-neues-mitglied-des-verwaltungsrats Turkmenistan Health News en PressRelease 2026-04-30T05:00:00+00:00 Santhera schlägt Dr. Srishti Gupta als neues Mitglied des Verwaltungsrats https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.turkmenistanhealthnews.com/article/909252198-santhera-proposes-dr-srishti-gupta-as-new-member-of-the-board-of-directors Turkmenistan Health News en PressRelease 2026-04-30T05:00:00+00:00 Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.turkmenistanhealthnews.com/article/909252203-addex-reports-full-year-2025-financial-results-and-provides-corporate-update Turkmenistan Health News en PressRelease 2026-04-30T05:00:00+00:00 Addex Reports Full Year 2025 Financial Results and Provides Corporate Update https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909252228-argenx-to-report-first-quarter-2026-financial-results-and-business-update-on-may-7-2026 Turkmenistan Health News en PressRelease 2026-04-30T05:00:00+00:00 argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.turkmenistanhealthnews.com/article/909205508-avalyn-announces-pricing-of-upsized-initial-public-offering Turkmenistan Health News en PressRelease 2026-04-30T01:00:53+00:00 Avalyn Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.turkmenistanhealthnews.com/article/909197138-mesoblast-reports-ryoncil-net-revenues-of-us-30-3m-and-improved-net-operating-cash-spend-for-the-quarter-to-us-4-1-million Turkmenistan Health News en PressRelease 2026-04-30T00:55:01+00:00 Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://www.turkmenistanhealthnews.com/article/909187732-vaccinex-reports-2025-annual-financial-results Turkmenistan Health News en PressRelease 2026-04-30T00:05:00+00:00 Vaccinex Reports 2025 Annual Financial Results https://ml.globenewswire.com/media/6a5e4bae-ba84-4fb3-a2ad-2cf268bfe3ba/small/vaccinex-logo.jpg https://www.turkmenistanhealthnews.com/article/909178327-logicmark-inc-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Turkmenistan Health News en PressRelease 2026-04-29T23:00:00+00:00 LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/a0f92be7-890f-496e-8c58-fc6621df90b0/small/logicmark-primary-color-png.png https://www.turkmenistanhealthnews.com/article/909141493-optimal-psma-trial-of-tlx597-tx-next-generation-rlt-presented-at-ipcs-2026-highlighting-therapeutic-potential-in-prostate-cancer Turkmenistan Health News en PressRelease 2026-04-29T21:00:00+00:00 OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.turkmenistanhealthnews.com/article/909141641-neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Turkmenistan Health News en PressRelease 2026-04-29T20:30:00+00:00 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://www.turkmenistanhealthnews.com/article/909141780-tarsus-to-report-first-quarter-2026-financial-results-on-wednesday-may-6-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:30:00+00:00 Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.turkmenistanhealthnews.com/article/909131872-crescent-biopharma-reports-first-quarter-2026-financial-results-and-recent-business-highlights Turkmenistan Health News en PressRelease 2026-04-29T20:15:00+00:00 Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.turkmenistanhealthnews.com/article/909133158-serotonin-centers-opens-second-north-texas-location-in-fort-worth-expanding-physician-led-longevity-care Turkmenistan Health News en PressRelease 2026-04-29T20:11:44+00:00 Serotonin Centers Opens Second North Texas Location in Fort Worth, Expanding Physician-Led Longevity Care https://ml.globenewswire.com/media/3ba07a05-1c88-4e05-bced-ca5d94e0462c/medium/serotonin-centers-fort-worth-team-at-new-location-opening.png https://www.turkmenistanhealthnews.com/article/909131707-lifestance-to-present-at-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-04-29T20:10:00+00:00 LifeStance to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.turkmenistanhealthnews.com/article/909131962-rxsight-inc-to-present-at-the-bank-of-america-healthcare-conference Turkmenistan Health News en PressRelease 2026-04-29T20:10:00+00:00 RxSight, Inc. to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://www.turkmenistanhealthnews.com/article/909131015-lifecore-biomedical-to-report-financial-results-for-the-first-quarter-ended-march-31-2026-on-may-6-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026 https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png https://www.turkmenistanhealthnews.com/article/909131035-revolution-medicines-to-report-financial-results-for-first-quarter-2026-after-market-close-on-may-6-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026 https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.turkmenistanhealthnews.com/article/909131048-bionano-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-webcast-on-may-13-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.turkmenistanhealthnews.com/article/909131141-invo-fertility-receives-nasdaq-notification-regarding-late-filing-of-annual-report-on-form-10-k Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K https://ml.globenewswire.com/media/c9819c81-8df5-472e-892b-610465571f75/small/invofertility-jpg.jpg https://www.turkmenistanhealthnews.com/article/909131147-dyadic-to-report-q1-2026-financial-results-and-host-conference-call-on-wednesday-may-13-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 https://ml.globenewswire.com/media/c67f7901-660b-41c0-a160-0f92fd04bb42/small/dyadic-applied-biosolutions-jpg.jpg https://www.turkmenistanhealthnews.com/article/909131331-ceribell-to-participate-in-the-bank-of-america-securities-2026-health-care-conference Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.turkmenistanhealthnews.com/article/909131510-sight-sciences-to-present-at-two-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Sight Sciences to Present at Two Upcoming Investor Conferences https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://www.turkmenistanhealthnews.com/article/909131575-mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/909132068-avita-medical-announces-tga-certification-in-australia-and-medsafe-wand-listing-in-new-zealand-for-recell-go Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.turkmenistanhealthnews.com/article/909132098-seer-to-report-first-quarter-2026-financial-results-on-may-13-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Seer to Report First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.turkmenistanhealthnews.com/article/909132115-maxcyte-to-report-first-quarter-2026-financial-results-on-may-12-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/8f0f0d48-fc4f-4d03-ac70-f4d096a780bd/small/maxcyte-logo-600x600-png.png https://www.turkmenistanhealthnews.com/article/909132131-teladoc-health-reports-first-quarter-2026-results Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Teladoc Health Reports First Quarter 2026 Results https://ml.globenewswire.com/media/439ced23-c1ca-477b-8607-8067a1777d11/small/tdh-logo-png.png https://www.turkmenistanhealthnews.com/article/909132256-relay-therapeutics-to-announce-first-quarter-2026-financial-results-and-corporate-highlights-on-may-5-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:05:00+00:00 Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026 https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.turkmenistanhealthnews.com/article/909132002-procept-biorobotics-reports-first-quarter-2026-financial-results Turkmenistan Health News en PressRelease 2026-04-29T20:03:00+00:00 PROCEPT BioRobotics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/fc9b1b79-13a0-4245-a974-081e3ceaafcb/small/procept-logo-png.PNG https://www.turkmenistanhealthnews.com/article/909131088-mannkind-to-report-first-quarter-2026-financial-results-on-may-6-2026 Turkmenistan Health News en PressRelease 2026-04-29T20:01:00+00:00 MannKind to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.turkmenistanhealthnews.com/article/909131236-olema-oncology-appoints-prakash-raman-ph-d-to-board-of-directors Turkmenistan Health News en PressRelease 2026-04-29T20:01:00+00:00 Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.turkmenistanhealthnews.com/article/909132033-mimedx-announces-first-quarter-2026-operating-financial-results Turkmenistan Health News en PressRelease 2026-04-29T20:01:00+00:00 MIMEDX Announces First Quarter 2026 Operating & Financial Results https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.turkmenistanhealthnews.com/article/909131040-parexel-adds-new-technology-capabilities-in-patient-safety-solutions-with-acquisition-of-vitrana Turkmenistan Health News en PressRelease 2026-04-29T20:00:00+00:00 Parexel Adds New Technology Capabilities in Patient Safety Solutions with Acquisition of Vitrana https://ml.globenewswire.com/media/9fb4b992-112d-493e-8212-d357da896d03/small/parexel-master-logo-cmyk-png.png